Structural-functional changes in the placent of samples submitted by nicotin action on the use of a new pharmaceutical composition

Authors

  • Sergienko L. Yu. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Kustova S. P. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Gevorkyan A. G. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Bondarenko T. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Sokolova S. S. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Perets E. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Cherevko A. N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Volokhov I. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Seliukova N. Yu. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2017.3.12

Keywords:

tobacco smoking, placenta, medicinal product

Abstract

It was investigated combined effect of passive smoking and reduced caloric nutrition during pregnancy without and against the background of the use of a new drug composition based on L-carnitine, hydrochloride and glycine with protective properties on the structural and functional changes in the placenta of female rats. The obtained results make it possible to consider this composition as promising in terms of creating a drug for primary prevention of gestational conditioned endocrinopathies.

References

Barker DJP, Eriksson JG, Forsйn T, Osmond C. Int J Epidemiol 2002; 31:1235-1239. https://doi.org/10.1093/intjepid/31.2.309

Bertram CE, Hanson MA. Reproduction 2002; 24(4):439-467.

Fowden AL, Giussani DA, Forhead AL. Physiology 2006; 21(1):29-37. https://doi.org/10.1152/physiol.00050.2005

Kajantie E. Ann NY Acad Sci 2006; 1083:11-27. https://doi.org/10.1196/annals.1367.026

Gladkova AY. Endokrynna patologija u vikovomu aspekti. Problemni pytannja: materialy nauk.-prakt. konf. z mizhnar. uchastju, Harkiv, 2010:44-55.

Knorre AG. Kratkij ocherk jembriologii cheloveka, Leningrad, 1967: 268 p.

Shenker Dzh. Akusherstvo i Ginekologija 1993; 3:39-42.

Bryzgalova GA, Sergienko LYu, Kartavtseva OV, Cherevko GM. Endocrinolology 1999; 4(2):210.

Suter M. Epigenetics 2011; 6:1284-1294. https://doi.org/10.4161/epi.6.11.17819

Owen D, Andrews M, Matthews S. Neurosci Biobehav Rev 2005; 29:209-226. https://doi.org/10.1016/j.neubiorev.2004.10.004

Saenger P, et al. Endocr Rev 2007; 28(2):219-251. https://doi.org/10.1210/er.2006-0039

Geary M, Crowley D, Boylan P. J Obstet Gynecol 1997; 17:264-265. https://doi.org/10.1080/01443619750113212

Wojtyla A, Gozdziewska M, Paprzycki P, Bilinski P. Ann Agric Environ Med 2012; 19(1):117-128.

Lambers DS, Clark KE. Semin Perinatаl 1996; 20:115-126.

Matta SG, et al. Psychopharmacology 2007; 190:269-319. https://doi.org/10.1007/s00213-006-0441-0

Onuki M, et al. J Occup Health 2003; 45:140-145. https://doi.org/10.1539/joh.45.140

Dempsey DA, Benowitz N L. Drug Saf 2001; 24:277-322. https://doi.org/10.2165/00002018-200124040-00005

Walther FJ, et al. Exp Lung Res 1991; 17:39-45. https://doi.org/10.3109/01902149109063280

Guo J, et al. J Biol Chem 2005; 280:30422-30431. https://doi.org/10.1074/jbc.M502121200

Genbacev O. Reprod Toxicol 2003; 17:509-518. https://doi.org/10.1016/S0890-62380300094-7

Hales CN, Ozanne SE. Diabetologia 2003; 46(7):1013-1019. https://doi.org/10.1007/s00125-003-1131-7

Ganguly A. J Nutr Biochem 2014; 25(2):259-266. https://doi.org/10.1016/j.jnutbio.2013.10.015

Pringle PJ, et al. J Clin Endocrinol Metab 2005; 90: 2556-2562. https://doi.org/10.1210/jc.2004-1674

Sergijenko LJu. Probl Endokryn Patologii’i’ 2015; 2:110-118.

Sergijenko LJu, Sokolova SS, Gjevorkjan AR, et al. Probl Endokryn Patologii’i’ 2017; 1:71-79.

Downloads

Published

2021-06-24

How to Cite

Sergienko, L. Y., Kustova, S. P., Gevorkyan, A. G., Bondarenko, T. V., Sokolova, S. S., Perets, E. V., Cherevko, A. N., Volokhov, I. V., & Seliukova, N. Y. (2021). Structural-functional changes in the placent of samples submitted by nicotin action on the use of a new pharmaceutical composition . Problems of Endocrine Pathology, 61(3), 86-93. https://doi.org/10.21856/j-PEP.2017.3.12

Most read articles by the same author(s)

1 2 3 > >>